Endotoxin contamination alters macrophage-cancer cell interaction and therapeutic efficacy in pre-clinical 3D in vitro models
Source abstract
Abstract
The rapid developments in biofabrication, in particular 3D bioprinting, in the recent years have facilitated the need for novel biomaterials that aim to replicate the target tissue in great detail. The presence of endotoxins in these biomaterials is often an overlooked problem. In pre-clinical 3D in vitro models, endotoxins can have significant influence on cell behavior and credibility of the model. In this study we demonstrate the effects of high levels of endotoxins in commercially-available gelatin on the macrophage-cancer cell crosstalk in a 3D bioprinted co-culture model. First, it is demonstrated that, while presenting the same mechanical and structural stimuli, high levels of endotoxin can have significant influence on the metabolic activity of macrophages and cancer cells. Furthermore, this study shows that high endotoxin contamination causes a strong inflammatory reaction in macrophages and significantly inhibits the effects of a paracrine macrophage-cancer cell co-culture. At last, it is demonstrated that the differences in endotoxin levels can drastically alter the efficacy of novel macrophage modulating immunotherapies, AS1517499 and 3-methyladenine. Altogether, this study shows that endotoxin contamination in biomaterials can significantly alter intra- and intercellular communication and thereby drug efficacy, which might lead to misinterpretation of the potency and safety of the tested compounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Biofabrication strategies for 3D in vitro models and regenerative medicine10.1038/s41578-018-0006-y ↗
2. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
3. 3D bioprinting of cells, tissues and organs
4. Engineered biomaterials for in situ tissue regeneration10.1038/s41578-020-0209-x ↗
5. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling
6. 3D bioprinting-based vascularized tissue models mimicking tissue-specific architecture and pathophysiology for in vitro studies
7. 3D bioprinting for reconstituting the cancer microenvironment
8. 3D in vitro model (R)evolution: unveiling tumor-stroma interactions, trends
9. 3D bioprinted cancer models: revolutionizing personalized cancer therapy10.1016/j.tranon.2021.101015 ↗
10. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models10.1016/j.addr.2021.04.018 ↗
11. Microenvironmental regulation of tumor progression and metastasis10.1038/nm.3394 ↗
12. Tumour-associated macrophages as treatment targets in oncology10.1038/nrclinonc.2016.217 ↗
13. Understanding the tumor immune microenvironment (TIME) for effective therapy10.1038/s41591-018-0014-x ↗
14. 3D tumor models and their use for the testing of immunotherapies
15. 3D-bioprinted mini-brain: a glioblastoma model to study cellular interactions and therapeutics
16. Endotoxins-the invisible companion in biomaterials research10.1089/ten.teb.2012.0636 ↗
17. Endotoxin: the uninvited guest10.1016/j.biomaterials.2005.04.063 ↗
18. Impact of endotoxins on bioengineered tissues and models10.1016/j.tibtech.2021.12.001 ↗
19. Impact of endotoxins in gelatine hydrogels on chondrogenic differentiation and inflammatory cytokine secretion in vitro10.3390/ijms21228571 ↗
20. Telocytes inhibited inflammatory factor expression and enhanced cell migration in LPS-induced skin wound healing models in vitro and in vivo10.1186/s12967-020-02217-y ↗
21. Releasing behavior of lipopolysaccharide from gelatin modulates inflammation, cellular senescence, and bone formation in critical-sized bone defects in rat calvaria10.3390/ma13010095 ↗
22. Endotoxin contamination delays the foreign body reaction10.1002/jbm.a.33144 ↗
23. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo10.1002/pros.23722 ↗
24. LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR410.1186/s13046-017-0552-y ↗
25. Extrusion bioprinting of shear-thinning gelatin methacryloyl bioinks10.1002/adhm.201601451 ↗
26. Influence of the mechanical properties of biomaterials on degradability, cell behaviors and signaling pathways: current progress and challenges10.1039/D0BM00269K ↗
27. Effect of lipopolysaccharide on toll-like receptor-4 signals in mouse cancer cells
28. Polysaccharide isolated from Tetrastigma hemsleyanum activates TLR4 in macrophage cell lines and enhances immune responses in OVA-immunized and LLC-bearing mouse models
29. Regulatory effects of lipopolysaccharide in murine macrophage proliferation10.3748/wjg.v4.i2.137 ↗
30. Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent10.1073/pnas.1518000113 ↗
31. Lipopolysaccharide-induced cell cycle arrest in macrophages occurs independently of nitric oxide synthase II induction10.1016/S0167-4889(01)00102-1 ↗
32. Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines10.4049/jimmunol.1201725 ↗
33. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent10.1016/j.jnutbio.2018.12.005 ↗
34. Macrophage plasticity in reproduction and environmental influences on their function
35. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo10.1371/journal.pone.0043483 ↗
36. Genomic signatures of breast cancer metastasis10.1159/000108292 ↗
37. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim2410.1038/s41467-019-12384-2 ↗
38. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer10.1096/fj.201700629R ↗
39. Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo10.1039/C9NR06505A ↗
40. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells10.1038/sj.neo.7900248 ↗
41. IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells10.1016/j.bbrc.2008.02.052 ↗
42. 3-methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition
43. Understanding how lipopolysaccharide impacts CD4 T cell immunity10.1615/CritRevImmunol.v28.i4.20 ↗
44. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling10.4049/jimmunol.179.1.41 ↗
45. The role of toll-like receptor 4 in tumor microenvironment10.18632/oncotarget.19105 ↗
46. TLR3 or TLR4 activation enhances mesenchymal stromal cell-mediated Treg induction via notch signaling10.1002/stem.2485 ↗
47. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung10.1172/jci.insight.98850 ↗
48. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma10.1016/j.ajpath.2012.09.007 ↗
49. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma10.1038/s41419-019-2059-2 ↗